论文部分内容阅读
高血压是抗血管生成药物常见不良反应之一,多为轻、中度。一般通过标准降压治疗即可控制,而严重者可影响患者的抗肿瘤疗效果甚至中断靶向药物治疗。因此,合理选择降压药物对于患者的抗肿瘤治疗具有重要意义。笔者主要探讨抗血管生成药物致高血压的降压药物选择,以期为临床用药提供参考。
Hypertension is one of the common side effects of anti-angiogenic drugs, mostly mild to moderate. Generally controlled by standard antihypertensive treatment, and severe cases can affect the patient’s anti-tumor effect or even interrupt the targeted drug treatment. Therefore, a reasonable choice of antihypertensive drugs for anti-cancer therapy in patients with great significance. The author mainly discusses antihypertensive drug-induced hypertension hypotensive drug selection, with a view to providing a reference for clinical use.